Are the serum levels of sCD40L modified by raloxifene in postmenopausal women?

被引:0
|
作者
Oviedo, Pilar J. [2 ]
Hermenegildo, Carlos [2 ,3 ]
Novella, Susana [2 ,3 ]
Tarin, Juan J. [4 ]
Cano, Antonio [1 ]
机构
[1] Univ Valencia, Dept Pediat, Sch Med & Dent, E-46010 Valencia, Spain
[2] Hosp Clin Univ Valencia, Res Fdn, Valencia, Spain
[3] Univ Valencia, Dept Physiol, E-46003 Valencia, Spain
[4] Univ Valencia, Dept Funct Biol & Phys Anthropol, E-46003 Valencia, Spain
关键词
D O I
10.1016/j.ejogrb.2008.05.001
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:296 / 297
页数:2
相关论文
共 50 条
  • [1] Serum levels of sCD30 and sCD40L in SLE patients
    Ciferska, H.
    Horak, P.
    Hermanova, Z.
    Ordeltova, J.
    Zadrazil, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 195 - 195
  • [2] Therapeutic dosages of oral or transdermal estradiol did not modify sCD40L levels in postmenopausal women
    Oviedo, Pilar J.
    Hermenegildo, Carlos
    Sobrino, Agua
    Tarin, Juan J.
    Cano, Antonio
    GYNECOLOGICAL ENDOCRINOLOGY, 2008, 24 (06) : 354 - 357
  • [3] Persistently higher serum sCD40L levels are associated with outcome in septic patients
    Yingjian Liang
    Chengrui Zhu
    Yini Sun
    Zhiliang Li
    Liang Wang
    Yina Liu
    Xin Li
    Xiaochun Ma
    BMC Anesthesiology, 21
  • [4] Persistently higher serum sCD40L levels are associated with outcome in septic patients
    Liang, Yingjian
    Zhu, Chengrui
    Sun, Yini
    Li, Zhiliang
    Wang, Liang
    Liu, Yina
    Li, Xin
    Ma, Xiaochun
    BMC ANESTHESIOLOGY, 2021, 21 (01)
  • [5] The Serum Levels of the Soluble Factors sCD40L and CXCL1 Are Not Indicative of Endometriosis
    Pateisky, Petra
    Pils, Dietmar
    Kuessel, Lorenz
    Szabo, Ladislaus
    Walch, Katharina
    Obwegeser, Reinhard
    Wenzl, Rene
    Yotova, Iveta
    BIOMED RESEARCH INTERNATIONAL, 2016, 2016
  • [6] Analysis of serum soluble CD40 ligand (sCD40L) in the patients undergoing allogeneic stem cell transplantation: platelet is a major source of serum sCD40L
    Nagasawa, M
    Zhu, Y
    Isoda, T
    Tomizawa, D
    Itoh, S
    Kajiwara, M
    Morio, T
    Nonoyama, S
    Shimizu, N
    Mizutani, S
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 74 (01) : 54 - 60
  • [7] Elevated levels of the proinflammatory mediator SCD40L in the metabolic syndrome
    Varo, N.
    Natal, C.
    Colina, I.
    Diez, J.
    JOURNAL OF HYPERTENSION, 2006, 24 : S146 - S146
  • [8] Elevated levels of the proinflammatory mediator sCD40L in the metabolic syndrome
    Varo, N.
    Natal, C.
    Colina, I.
    Díez, J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 415 - 416
  • [9] Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases
    Goules, Andreas
    Tzioufas, Athanasios G.
    Manousakis, Menelaos N.
    Kirou, Kyriakos A.
    Crow, Mary K.
    Routsias, John G.
    JOURNAL OF AUTOIMMUNITY, 2006, 26 (03) : 165 - 171
  • [10] Serum sCD40L levels are increased in patients with psoriatic arthritis and are associated with clinical response to apremilast
    Venerito, V.
    Natuzzi, D.
    Bizzoca, R.
    Lacarpia, N.
    Cacciapaglia, F.
    Lopalco, G.
    Iannone, F.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2020, 201 (02): : 200 - 204